SAN FRANCISCO, Jan 13 (Reuters) - AstraZeneca has agreed to buy Boston-based Modella AI, the companies said on Tuesday, as the drug industry increases its use of artificial intelligence to accelerate the discovery of new drugs.
The companies did not disclose financial terms. In a press release, Modella AI said its "foundation models" and AI agents would be integrated into oncology research and development to support clinical development and biomarker discovery.
"Oncology drug development is becoming more complex, more data-rich and more time-sensitive," said Gabi Raia, Modella AI's chief commercial officer, adding that joining AstraZeneca would allow it to deploy its tools in global trials and clinical settings.
AstraZeneca said that this was the first acquisition of an AI firm by a big pharmaceutical company.
In an interview at the JP Morgan Healthcare Conference, AstraZeneca Chief Financial Officer Aradhana Sarin said the acquisition would "supercharge" the company's quantitative pathology and biomarker discovery efforts by bringing more data and AI capabilities in-house.
The deal was one of a number of pacts between major drug firms and AI companies that were unveiled at the healthcare conference, including a $1 billion collaboration between Nvidia and Eli Lilly. They plan to build a new research lab using Nvidia's latest-generation AI chips.
Modella will accelerate AstraZeneca’s efforts to make pathology more quantitative - using computers to analyze biopsies for relevant proteins and correlate them with clinical data - so AstraZeneca can develop “highly targeted biomarkers and then highly targeted therapeutics,” Sarin said.
The deal is an expansion of a multi-year collaboration that the companies unveiled in July.
Sarin said that partnership served as a "test drive," adding that AstraZeneca ultimately wanted Modella's data, foundation models and AI talent in-house.
She said AI tools could be used to more rapidly select patients for drug trials, which could increase the odds of clinical success and cut related costs.
(Reporting by Maggie Fick; Editing by Thomas Derpinghaus)
LATEST POSTS
- 1
Louisiana seeks California doctor’s extradition, testing the limits of shield laws - 2Employers and staff feel effect of fuel price rise
- 3Instructions to Pick the Right Toothbrush for Your Teeth
- 4Nearly 16,000 New York City nurses prepare to strike as contract talks stall
- 5What to watch for in weight loss drugs in 2026
- Munich Security Conference chief defends inviting AfD lawmakers
- Fact Check: Some Bridge Photos Circulating Do NOT Show The Hongqi Bridge That Collapsed In Southwest China Nov. 11, 2025
- How to sound like an astronaut as you follow the first human moon mission in more than half a century
- Carnival fever hits Lagos as locals celebrate Afro-Brazilian heritage
- Woman, 60, Is Finally Traveling the World Decades After Husband’s Death Held Her Back
- NASA is sending astronauts back to the moon. Can you see the Artemis 4 landing sites from Earth?
- This Canadian crater looks like marbled meat | Space photo of the day for Jan. 6, 2026
- Vote in favor of Your Number one BWM Vehicles
- RFK Jr.'s diet guidelines emphasize red meat, full-fat dairy. How healthy are they?
